The potential theragnostic (diagnostic+therapeutic) application of exosomes in diverse biomedical fields

다국어 초록 (Multilingual Abstract)

Exosomes are membranous vesicles of 30-150 nm in diameter that are derived from the exocytosis of the intraluminal vesicles of many cell types including immune cells, stem cells, cardiovascular cells and tumor cells. Exosomes participate in intercellular communication by delivering their contents to recipient cells, with or without direct contact between cells, and thereby influence physiological and pathological processes. They are present in various body fluids and contain proteins, nucleic acids, lipids, and microRNAs that can be transported to surrounding cells.
Theragnosis is a concept in next-generation medicine that simultaneously combines accurate diagnostics with therapeutic effects. Molecular components in exosomes have been found to be related to certain diseases and treatment responses, indicating that they may have applications in diagnosis via molecular imaging and biomarker detection. In addition, recent studies have reported that exosomes have immunotherapeutic applications or can act as a drug delivery system for targeted therapies with drugs and biomolecules. In this review, we describe the formation, structure, and physiological roles of exosomes. We also discuss their roles in the pathogenesis and progression of diseases including neurodegenerative diseases, cardiovascular diseases, and cancer. The potential applications of exosomes for theragnostic purposes in various diseases are also discussed. This review summarizes the current knowledge about the physiological and pathological roles of exosomes as well as their diagnostic and therapeutic uses, including emerging exosome-based therapies that could not be applied until now.

참고문헌 (Reference)

• 1 Viaud S, "Updated technology to produce highly immunogenic dendritic cell-derived exosomes of clinical grade: a critical role of interferon-$\gamma$" 34 : 65-75, 2011
• 2 Bobrie A, "Unraveling the physiological functions of exosome secretion by tumors" 2 : e22565-, 2013
• 3 Mittelbrunn M, "Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells" 2 : 282-, 2011
• 4 Zwicker JI, "Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy" 15 : 6830-6840, 2009
• 5 Wieckowski EU, "Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes" 183 : 3720-3730, 2009
• 6 Szajnik M, "Tumor-derived microvesicles induce, expand and upregulate biological activities of human regulatory T cells (Treg)" 5 : e11469-, 2010
• 7 Zhuang X, "Treatment of brain inflammatory diseases by delivering exosome encapsulated antiinflammatory drugs from the nasal region to the brain" 19 : 1769-1779, 2011
• 8 Gutierrez-Vazquez C, "Transfer of extracellular vesicles during immune cell-cell interactions" 251 : 125-142, 2013
• 9 Tan M, "Thrombin stimulated platelet-derived exosomes inhibit platelet-derived growth factor receptor-beta expression in vascular smooth muscle cells" 38 : 2348-2365, 2016
• 10 Hedlund M, "Thermal- and oxidative stress causes enhanced release of NKG2D ligand-bearing immunosuppressive exosomes in leukemia/lymphoma T and B cells" 6 : e16899-, 2011
• 11 Yang C, "The roles of tumor-derived exosomes in cancer pathogenesis" 2011 : 842849-, 2011
• 12 Suades R, "The role of blood-borne microparticles in inflammation and hemostasis" 41 : 590-606, 2015
• 13 Jung T, "The proteasomal system" 30 : 191-296, 2009
• 14 Hoebe K, "The interface between innate and adaptive immunity" 5 : 971-974, 2004
• 15 Henne WM, "The ESCRT pathway" 21 : 77-91, 2011
• 16 Zoller M, "Tetraspanins: push and pull in suppressing and promoting metastasis" 9 : 40-55, 2009
• 17 Andreu Z, "Tetraspanins in extracellular vesicle formation and function" 5 : 442-, 2014
• 18 Baietti MF, "Syndecan-syntenin-ALIX regulates the biogenesis of exosomes" 14 : 677-685, 2012
• 19 Villarroya-Beltri C, "Sorting it out: regulation of exosome loading" 28 : 3-13, 2014
• 20 Kantoff PW, "Sipuleucel-T immunotherapy for castration-resistant prostate cancer" 363 : 411-422, 2010
• 21 Cocucci E, "Shedding microvesicles: artefacts no more" 19 : 43-51, 2009
• 22 Takeshita N, "Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma" 108 : 644-652, 2013
• 23 Fitzner D, "Selective transfer of exosomes from oligodendrocytes to microglia by macropinocytosis" 124 : 447-458, 2011
• 24 McCready J, "Secretion of extracellular hsp90alpha via exosomes increases cancer cell motility: a role for plasminogen activation" 10 : 294-, 2010
• 25 Biasutto L, "Retinal pigment epithelium (RPE) exosomes contain signaling phosphoproteins affected by oxidative stress" 319 : 2113-2123, 2013
• 26 Cheng V, "Restoration of glycemic control in patients with type 2 diabetes mellitus after bariatric surgery is associated with reduction in microparticles" 9 : 207-212, 2013
• 27 Polo V, "Reliability and validity of Cirrus and Spectralis optical coherence tomography for detecting retinal atrophy in Alzheimer's disease" 28 : 680-690, 2014
• 28 Thery C, "Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles" 166 : 7309-7318, 2001
• 29 Nilsson J, "Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer" 100 : 1603-1607, 2009
• 30 Lamparski HG, "Production and characterization of clinical grade exosomes derived from dendritic cells" 270 : 211-226, 2002
• 31 Yuyama K, "Physiological and pathological roles of exosomes in the nervous system" 7 : 53-68, 2016
• 32 Palanisamy V, "Nanostructural and transcriptomic analyses of human saliva derived exosomes" 5 : e8577-, 2010
• 33 Barry OP, "Modulation of monocyte-endothelial cell interactions by platelet microparticles" 102 : 136-144, 1998
• 34 Lakhter AJ, "Minireview: emerging roles for extracellular vesicles in diabetes and related metabolic disorders" 29 : 1535-1548, 2015
• 35 Grange C, "Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche" 71 : 5346-5356, 2011
• 36 van Dommelen SM, "Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery" 161 : 635-644, 2012
• 37 Lawson C, "Microvesicles and exosomes: new players in metabolic and cardiovascular disease" 228 : R57-R71, 2016
• 38 Li J, "Microvesicle-mediated transfer of microRNA-150 from monocytes to endothelial cells promotes angiogenesis" 288 : 23586-23596, 2013
• 39 Stepanian A, "Microparticle increase in severe obesity: not related to metabolic syndrome and unchanged after massive weight loss" 21 : 2236-2243, 2013
• 40 Parolini I, "Microenvironmental pH is a key factor for exosome traffic in tumor cells" 284 : 34211-34222, 2009
• 41 Lv LL, "MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis" 305 : F1220-F1227, 2013
• 42 Bruno S, "Mesenchymal stem cell-derived microvesicles protect against acute tubular injury" 20 : 1053-1067, 2009
• 43 Baglio SR, "Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy" 3 : 359-, 2012
• 44 Thery C, "Membrane vesicles as conveyors of immune responses" 9 : 581-593, 2009
• 45 Peinado H, "Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET" 18 : 883-891, 2012
• 46 Montecalvo A, "Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes" 119 : 756-766, 2012
• 47 Andre F, "Malignant effusions and immunogenic tumour-derived exosomes" 360 : 295-305, 2002
• 48 Runz S, "Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM" 107 : 563-571, 2007
• 49 Kordelas L, "MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease" 28 : 970-973, 2014
• 50 Utsugi-Kobukai S, "MHC class I-mediated exogenous antigen presentation by exosomes secreted from immature and mature bone marrow derived dendritic cells" 89 : 125-131, 2003
• 51 Pignon JP, "Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group" 26 : 3552-3559, 2008
• 52 Takata K, "Localization and trafficking of aquaporin 2 in the kidney" 130 : 197-209, 2008
• 53 Smalley DM, "Isolation and identification of potential urinary microparticle biomarkers of bladder cancer" 7 : 2088-2096, 2008
• 54 Hannafon BN, "Intercellular communication by exosomederived microRNAs in cancer" 14 : 14240-14269, 2013
• 55 Peterson MF, "Integrated systems for exosome investigation" 87 : 31-45, 2015
• 56 Kuwabara Y, "Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage" 4 : 446-454, 2011
• 57 Yang C, "Immunosuppressive exosomes: a new approach for treating arthritis" 2012 : 573528-, 2012
• 58 Segura E, "ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming" 106 : 216-223, 2005
• 59 Lasser C, "Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages" 9 : 9-, 2011
• 60 Pap E, "Highlights of a new type of intercellular communication: microvesicle-based information transfer" 58 : 1-8, 2009
• 61 Logozzi M, "High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients" 4 : e5219-, 2009
• 62 Skog J, "Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers" 10 : 1470-1476, 2008
• 63 Zhou H, "Genome-scale RNAi screen for host factors required for HIV replication" 4 : 495-504, 2008
• 64 Qu JL, "Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation" 41 : 875-880, 2009
• 65 Kalra H, "Focus on extracellular vesicles: introducing the next small big thing" 17 : 170-, 2016
• 66 Raposo G, "Extracellular vesicles: exosomes, microvesicles, and friends" 200 : 373-383, 2013
• 67 Zaborowski MP, "Extracellular vesicles: composition, biological relevance, and methods of study" 65 : 783-797, 2015
• 68 EL Andaloussi S, "Extracellular vesicles: biology and emerging therapeutic opportunities" 12 : 347-357, 2013
• 69 Doeppner TR, "Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression" 4 : 1131-1143, 2015
• 70 Simpson RJ, "Exosomes: proteomic insights and diagnostic potential" 6 : 267-283, 2009
• 71 Lin J, "Exosomes: novel biomarkers for clinical diagnosis" 2015 : 2015
• 72 Madison MN, "Exosomes: implications in HIV-1 pathogenesis" 7 : 4093-4118, 2015
• 73 Mathivanan S, "Exosomes: extracellular organelles important in intercellular communication" 73 : 1907-1920, 2010
• 74 Thery C, "Exosomes: composition, biogenesis and function" 2 : 569-579, 2002
• 75 Zhang HG, "Exosomes: a novel pathway of local and distant intercellular communication that facilitates the growth and metastasis of neoplastic lesions" 184 : 28-41, 2014
• 76 Taylor DD, "Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments" 33 : 441-454, 2011
• 77 Rahman MJ, "Exosomes released by islet-derived mesenchymal stem cells trigger autoimmune responses in NOD mice" 63 : 1008-1020, 2014
• 78 Lee C, "Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension" 126 : 2601-2611, 2012
• 79 Howitt J, "Exosomes in the pathology of neurodegenerative diseases" 291 : 26589-26597, 2016
• 80 McGough IJ, "Exosomes in developmental signalling" 143 : 2482-2493, 2016
• 81 El Andaloussi S, "Exosomes for targeted siRNA delivery across biological barriers" 65 : 391-397, 2013
• 82 Lee JK, "Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells" 8 : e84256-, 2013
• 83 Zhang Y, "Exosomes derived from IL-12-anchored renal cancer cells increase induction of specific antitumor response in vitro: a novel vaccine for renal cell carcinoma" 36 : 133-140, 2010
• 84 Eldh M, "Exosomes communicate protective messages during oxidative stress; possible role of exosomal shuttle RNA" 5 : e15353-, 2010
• 85 Chaput N, "Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection" 172 : 2137-2146, 2004
• 86 Andre F, "Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells" 172 : 2126-2136, 2004
• 87 Hsu DH, "Exosomes as a tumor vaccine: enhancing potency through direct loading of antigenic peptides" 26 : 440-450, 2003
• 88 Schorey JS, "Exosomes and other extracellular vesicles in host-pathogen interactions" 16 : 24-43, 2015
• 89 Xin H, "Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth" 30 : 1556-1564, 2012
• 90 Valadi H, "Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells" 9 : 654-659, 2007
• 91 Lai RC, "Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury" 4 : 214-222, 2010
• 92 Sharma S, "Epigenetics in cancer" 31 : 27-36, 2010
• 93 Huotari J, "Endosome maturation" 30 : 3481-3500, 2011
• 94 Morelli AE, "Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells" 104 : 3257-3266, 2004
• 95 Chen TS, "Efficiency of exosome production correlates inversely with the developmental maturity of MSC donor" 3 : 145-, 2013
• 96 Zhang Y, "Effect of exosomes derived from multipluripotent mesenchymal stromal cells on functional recovery and neurovascular plasticity in rats after traumatic brain injury" 122 : 856-867, 2015
• 97 Hurley JH, "ESCRTs are everywhere" 34 : 2398-2407, 2015
• 98 Tanaka M, "Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients" 4 : e5532-, 2009
• 99 Crescitelli R, "Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes" 2 : 20677-, 2013
• 100 Pisitkun T, "Discovery of urinary biomarkers" 5 : 1760-1771, 2006
• 101 Tran TH, "Development of a graphene oxide nanocarrier for dual-drug chemo-phototherapy to overcome drug resistance in cancer" 7 : 28647-28655, 2015
• 102 Hunter MP, "Detection of microRNA expression in human peripheral blood microvesicles" 3 : e3694-, 2008
• 103 Besse B, "Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC" 5 : e1071008-, 2015
• 104 Alvarez-Erviti L, "Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes" 29 : 341-345, 2011
• 105 Ahmad M, "Comparison of bioavailability and pharmacokinetics of diclofenac sodium and diclofenac potassium in healthy and Escherichia coli induced febrile rabbits" 42 : 395-400, 2010
• 106 Yoshioka Y, "Comparative marker analysis of extracellular vesicles in different human cancer types" 2 : 20424-, 2013
• 107 Ahmad M, "Comparative bioavailability and pharmacokinetics of flurbiprofen 200 mg SR pellets from India and France" 20 : 599-604, 2011
• 108 Chen CL, "Comparative and targeted proteomic analyses of urinary microparticles from bladder cancer and hernia patients" 11 : 5611-5629, 2012
• 109 Zhou H, "Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery" 69 : 1471-1476, 2006
• 110 Tanaka Y, "Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma" 119 : 1159-1167, 2013
• 111 van der Pol E, "Classification, functions, and clinical relevance of extracellular vesicles" 64 : 676-705, 2012
• 112 Mitchell PS, "Circulating microRNAs as stable blood-based markers for cancer detection" 105 : 10513-10518, 2008
• 113 Brase JC, "Circulating miRNAs are correlated with tumor progression in prostate cancer" 128 : 608-616, 2011
• 114 de Jong OG, "Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes" 1 : 18396-, 2012
• 115 Skinner AM, "Cellular microvesicle pathways can be targeted to transfer genetic information between non-immune cells" 4 : e6219-, 2009
• 116 Segura E, "CD8+ dendritic cells use LFA-1 to capture MHC-peptide complexes from exosomes in vivo" 179 : 1489-1496, 2007
• 117 Keller S, "CD24 is a marker of exosomes secreted into urine and amniotic fluid" 72 : 1095-1102, 2007
• 118 Jang SC, "Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors" 7 : 7698-7710, 2013
• 119 Kowal J, "Biogenesis and secretion of exosomes" 29 : 116-125, 2014
• 120 Khiljee S, "Bioequivalence evaluation of norfloxacin tablets based on in vitro - in vivo correlation" 24 : 421-426, 2011
• 121 Raposo G, "B lymphocytes secrete antigen-presenting vesicles" 183 : 1161-1172, 1996
• 122 Li T, "Autologous bone marrow-derived mesenchymal stem cell transplantation promotes liver regeneration after portal vein embolization in cirrhotic rats" 184 : 1161-1173, 2013
• 123 Amabile N, "Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study" 35 : 2972-2979, 2014
• 124 Hendrix A, "An ex(o)citing machinery for invasive tumor growth" 70 : 9533-9537, 2010
• 125 Xu W, "Aggf1 attenuates hepatic inflammation and activation of hepatic stellate cells by repressing Ccl2 transcription" 31 : 1-9, 2016
• 126 Yang Y, "Acquisition of new tumor cell properties by MSC-derived exosomes" 47 : 244-252, 2015
• 127 Morse MA, "A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer" 3 : 9-, 2005
• 128 Sun D, "A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes" 18 : 1606-1614, 2010
• 129 Taylor DD, ""Membrane-associated" immunoglobulins in cyst and ascites fluids of ovarian cancer patients" 3 : 7-11, 1983